IBS
32
3
3
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
2 terminated out of 32 trials
91.3%
+4.8% vs benchmark
19%
6 trials in Phase 3/4
10%
2 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (32)
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD
Ebastine Versus Mebeverine in IBS Patients
Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial
Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome
Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C
Comparison of the Atmo Motility Gas Capsule System to the Reference Standard
Systems Biology of Gastrointestinal and Related Diseases
The Living With a Long-Term Condition Study
Gabapral in Pediatric IBS
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
Confocal Laser Endomicroscopy in IBS Patients
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome
Health Effects of Different Types of Bread
A Study of Probiotics in IBS Subjects
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS